Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2003
09/17/2003EP1344824A1 Mutated gene coding for a LAT protein and the biological applications thereof
09/17/2003EP1344064A2 Compositions and methods relating to prostate specific genes and proteins
09/17/2003EP1343900A2 Oxidoreductases
09/17/2003EP1343891A2 Colon cancer marker
09/17/2003EP1343890A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/17/2003EP1343887A2 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof
09/17/2003EP1343886A2 Compositions and methods for the therapy and diagnosis of lung cancer
09/17/2003EP1343880A2 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates
09/17/2003EP1343875A2 Sugar beet genes involved in stress tolerance
09/17/2003EP1343823A2 Antithrombotic von willebrand factor (vwf) collagen bridging blockers
09/17/2003EP1343822A2 Means for the diagnosis and therapy of ctcl
09/17/2003EP1343821A2 Method of producing antibodies by immunization with conjugates of molecules coupled to charge-modified proteins
09/17/2003EP1343820A1 Human anti-epidermal growth factor receptor single-chain antibodies
09/17/2003EP1343814A2 Immunogenic glycopeptides, screening, preparation and uses
09/17/2003EP1343527A2 Adjuvant combination formulations
09/17/2003EP1343524A1 Vaccine based on a cellular penetration factor from an apicomplexan parasite
09/17/2003EP1124941B1 Process for recovering heterologous polypeptides from bacterial cells
09/17/2003EP0981627B1 Purified telomerase
09/17/2003EP0972782B1 Monoclonal antibody which recognizes the oligosaccharide n-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it
09/17/2003EP0842428B1 Process for producing gm2 specific antibodies
09/17/2003EP0697888B1 Conserved motif of hepatitis c virus e2/ns1 region
09/17/2003EP0669988B1 Angiogenesis inhibitory antibodies
09/17/2003EP0571613B1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
09/17/2003CN1443240A Interferon-like protein zcyto 21
09/17/2003CN1443239A Compositions and methods for therapy and diagnosis of breast cancer
09/17/2003CN1443199A Antibodies to human MCP-1
09/17/2003CN1443192A Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
09/17/2003CN1443077A CD40-binding APC-activating molecules
09/17/2003CN1443074A Methods and compositions for inhibiting immunoglobulin-mediated reperfusion injury
09/17/2003CN1442429A Preparation method of human source anti-HBsFab
09/16/2003US6620923 Use for treatment of uterine cancer
09/16/2003US6620918 Isolation of preferential particles from solution; apply sample solution to exchange resin, elute and recover preferential particle from exchange resin
09/16/2003US6620915 Monoclonal antibodies specific for integrin α-d subunit
09/16/2003US6620789 Compounds are provided that inhibit the interaction of an IGF with any one of its binding proteins and not to a human IGF receptor. These IGF agonist compounds, which include peptides, are useful to increase serum and tissue levels of active IGFs
09/16/2003US6620784 Uses of VEGF-E
09/16/2003US6620783 Human SMN-like protein (HSLP) and polynucleotides which identify and encode HSLP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating
09/16/2003US6620606 New human cathepsin (LCAP) and polynucleotides which identify and encode LCAP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders
09/16/2003US6620587 Ribosome complexes as selection particles for in vitro display and evolution of proteins
09/16/2003US6620412 Prophylactic and therapeutic monoclonal antibodies
09/16/2003CA2145985C Vascular endothelial cell growth factor antagonists
09/16/2003CA2140252C A snow grooming device
09/16/2003CA2131719C Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor
09/16/2003CA2119463C Glial cell line-derived neutrophic factor
09/12/2003WO2003075009A1 Use of nucloeoside derivatives comprising a citrate group for producing antibodies having affinity for triphosphorylated nucleosides and uses thereof
09/12/2003WO2003074705A1 Proteins capable of binding to environmental hormones and process for producing the same
09/12/2003WO2003074704A1 Proteins capable of binding to female sex hormones and process for producing the same
09/12/2003WO2003074694A1 Adipocyte differentiation-associated genes and proteins
09/12/2003WO2003074687A1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
09/12/2003WO2003074679A2 Antibody optimization
09/12/2003WO2003074664A2 Cloning and characterization of slc26a7 and slc26a9 anion exchangers
09/12/2003WO2003074569A2 Bispecific antibody point mutations for enhancing rate of clearance
09/12/2003WO2003074568A1 Individualized anti-cancer antibodies
09/12/2003WO2003074567A2 Internalizing anti-cd74 antibodies and methods of use
09/12/2003WO2003074563A2 Means and methods for manipulating hypersensitivity-like responses
09/12/2003WO2003074558A2 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
09/12/2003WO2003074549A2 Assay for anti-ingap antibodies
09/12/2003WO2003074543A1 Anti-protozoal vaccine
09/12/2003WO2003074081A1 SPECIFIC ANTIBODIES TO AMYLOID β PEPTIDE, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF
09/12/2003WO2003074073A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
09/12/2003WO2003074003A2 Immunogens for treatment of neoplastic and infectious disease
09/12/2003WO2003073993A2 Binding of red blood cell to exposed subendothelial surfaces to impede platelet deposition thereon and/or for use in targeted drug delivery thereto
09/12/2003WO2003073982A2 Anti-interleukin-1 beta analogs
09/12/2003WO2003073981A2 Novel of cytokine inhibitors
09/12/2003WO2003073916A2 Immune regulation
09/12/2003WO2003073821A2 Shc PROTEIN-RELATED METHODS AND COMPOSITIONS FOR THE PROGNOSIS OF BREAST, PROSTATE AND OVARIAN CANCER
09/12/2003WO2003065973A8 Multivalent streptococcal vaccine compositions and methods for use
09/12/2003WO2003035884A3 Transient immortalization
09/12/2003WO2003032814A3 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof
09/12/2003WO2003018596A3 Method for removing endotoxins from protein solutions
09/12/2003WO2003007794A3 Invasion complex and methods of targeting
09/12/2003WO2002082041A3 Production and use of novel peptide-based agents for use with bi-specific antibodies
09/12/2003WO2002080966A3 Method for producing a vaccine containing autologous antibodies
09/12/2003WO2002075507A3 Anti-bacterial vaccine compositions
09/12/2003WO2002072830A3 Proteins associated with cell growth, differentiation, and death
09/12/2003WO2002062205A3 Methods for diagnosing and treating heart disease
09/12/2003WO2002061071A3 Focused libraries of genetic packages
09/12/2003WO2002052011A3 A novel human leucine-rich repeat containing protein expressed predominately in bone marrow, hlrrbm1
09/12/2003WO2002048370A3 Compositions and methods relating to colon specific genes and proteins
09/12/2003WO2002032961A8 Novel polypeptides and nucleic acids encoding same
09/12/2003WO2002029015A9 Assay for rapid detection of human activated protein c and highly specific monoclonal antibody therefor
09/12/2003CA2818688A1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
09/12/2003CA2478649A1 Means and methods for manipulating hypersensitivity-like responses
09/12/2003CA2478636A1 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
09/12/2003CA2478378A1 Novel use of cytokine inhibitors
09/12/2003CA2478047A1 Rs7 antibodies
09/12/2003CA2478011A1 Bispecific antibody point mutations for enhancing rate of clearance
09/12/2003CA2477953A1 Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer
09/12/2003CA2477794A1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
09/12/2003CA2477662A1 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
09/12/2003CA2477566A1 Cloning and characterization of slc26a7 and slc26a9 anion exchangers
09/12/2003CA2476979A1 Assay for anti-ingap antibodies
09/12/2003CA2476182A1 Conjugates of therapeutic or cytotoxic agents and biologically active peptides
09/12/2003CA2456077A1 Individualized anti-cancer antibodies
09/11/2003WO2003074566A2 Rs7 antibodies
09/11/2003WO2003074551A2 Conjugates of therapeutic or cytotoxic agents and biologically active peptides
09/11/2003US20030172407 Method of producing single chain protein in plant cells
09/11/2003US20030172391 A transgenic mouse; the enzyme for treating inflammation, smooth muscle contraction; animal models
09/11/2003US20030172389 Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
09/11/2003US20030172388 Methods and compositions relating to fortilin, an anti-apoptotic molecule, and modulators of fortilin
09/11/2003US20030171568 Diagnosing tumor or cancer in a mammal, and inflammatory diseases or disorders; inflammatory bowel disease, colon cancer; immunoassay, immunotherapy
1 ... 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 ... 1494